BNP Paribas

Databricks Inc. is a technology company that provides a unified data analytics cloud platform designed to facilitate data engineering and collaborative data science. The company offers a comprehensive suite of tools, including a just-in-time data platform that simplifies data integration, real-time experimentation, and deployment of production applications for developers and data scientists. Key products include Databricks Delta, which combines the capabilities of data warehouses with low-latency streaming, MLflow for managing the machine learning lifecycle, and Delta Lake for handling batch and streaming data. Databricks serves a diverse range of industries, including advertising, healthcare, manufacturing, and telecommunications, and has established strategic partnerships with various organizations to enhance its offerings. Founded in 2013, Databricks is headquartered in San Francisco, California, with additional offices in London, Amsterdam, and Bengaluru.

Aladom is a web portal established in France in 2008, designed to connect individuals seeking home services with various service providers. Originally launched as "the genie of home services," Aladom.fr features over 85,000 classified advertisements across more than 70 categories, including childcare, personal assistance, tutoring, cleaning, and gardening. The platform aims to facilitate the hiring process for clients looking to meet their daily needs. Since its inception, Aladom has expanded its services internationally, launching in Germany, Belgium, and the USA, and later in Spain, thereby broadening its reach and enhancing its offerings in the home services sector.

Aerospacelab SA, founded in 2017 and headquartered in Mont-Saint-Guibert, Belgium, specializes in the development and manufacture of small satellites equipped with advanced sensors. The company focuses on creating satellite imagery technology that captures high-resolution optical data, allowing for frequent data collection. In addition to satellite production, Aerospacelab develops tools that utilize artificial intelligence and machine learning to automate various tasks, facilitating processes such as surveying and monitoring. This innovative approach enables customers to efficiently analyze substantial volumes of data and optimize the extraction of valuable insights from the information gathered.

Maltem Consulting Group is a consulting firm that specializes in organizational consulting and project ownership in information systems management. Founded in 2001 and headquartered in Neuilly-sur-Seine, France, the company provides a range of services including business analysis, systems integration, infrastructure management, and the development of business solutions. It primarily serves clients in the financial, banking, insurance, energy, telecommunications, and media sectors. Maltem Consulting operates additional offices in major cities across Europe, Asia, and North America, allowing it to cater to a diverse clientele with varying digital transformation and data management needs. The firm is recognized for its expertise in agile technology, design experience, and cybersecurity, positioning it as a key player in the consulting landscape.

Dynamic Credit, headquartered in Amsterdam, Netherlands, is a financial services firm specializing in asset management and direct lending. The company focuses on creating a better alignment between savings and credit to foster a more sustainable and prosperous society. Through its platform, Dynamic Credit offers tailored financial solutions that cater to the needs of both savers and borrowers.

Arrival Communications, established in 1991 and headquartered in Bakersfield, California, specializes in providing voice and data communication services to businesses in Central California. The company offers a range of services, including local and long-distance voice services, dedicated networks, integrated solutions, and data services such as high-speed internet access and mobile wireless services. Notably, Arrival Communications is building a facilities-based network to serve businesses in smaller cities throughout the Western United States, expanding its reach and capabilities.

reMYND NV is a biotechnology company based in Leuven, Belgium, focused on developing disease-modifying treatments for neurodegenerative and metabolic disorders, including Alzheimer’s, Parkinson’s, and diabetes. The company is known for its investigational compounds, such as ReS19-T, aimed at treating Alzheimer’s, and ReS39, which targets diabetes. Additionally, reMYND is advancing ReS3-T, a program that addresses both Alzheimer’s and epilepsy by regulating neuronal activity. The company utilizes a phenotypic screening platform to discover small molecule treatments that counteract the toxicity of misfolded proteins associated with these diseases. As a contract research organization (CRO), reMYND also assists clients, including major pharmaceutical companies in the United States, Europe, and Japan, by providing in-vivo assessments of experimental treatments using proprietary mouse models. Founded in 2002, reMYND has established a reputation for delivering pivotal proof-of-concept data that supports drug development in protein misfolding disorders.

eTheRNA Immunotherapies NV is a Belgium-based biotechnology company that specializes in the development of mRNA-based immunotherapies. Founded in 2013 and located in Niel, the company focuses on harnessing the immune system's dendritic cells to create treatments for melanoma, triple-negative breast cancer, and infectious diseases. eTheRNA has developed innovative TriMix technology that enhances the immune response, enabling patients to better combat these diseases. The company aims to be a leader in nucleic acid-based medicines, collaborating with partners to facilitate the creation of new drugs and improve patient outcomes. Additionally, eTheRNA has established a strategic partnership with China Grand Pharmaceutical and Healthcare Holdings Limited to further its mission.

iSTAR Medical SA is a Belgian company specializing in the development of innovative ophthalmic implants aimed at treating glaucoma. Founded in 2010 as a spinout of Healionics Corporation, the company has established itself in the field with its flagship product, the STARflo glaucoma implant. This non-degradable, precision-pore device functions as a micro-porous drainage system that reduces intraocular pressure by enhancing the eye’s natural uveoscleral outflow. iSTAR Medical's offerings also include STARflo PLUS and STARflo MINI surgical therapies, which incorporate anti-fibrotic and anti-inflammatory properties to improve patient outcomes. The company operates from its eco-friendly R&D and manufacturing facility in CREALYS Scientific Park near Namur, Belgium, and distributes its products through various international partners across Europe and Asia. iSTAR Medical is committed to providing advanced and effective treatment alternatives for glaucoma patients, with its devices designed to limit inflammation and fibrosis while promoting bio-integration with surrounding tissues.

SET Ventures, established in 2007 and based in Amsterdam, Netherlands, is a venture capital firm focusing on early to growth-stage investments in Europe. The company specializes in digital technology for a carbon-free energy system, backing pioneering startups with sustainable solutions and a strong digital DNA. Its investment priority lies in sectors such as distributed infrastructure, energy retail, buildings, mobility, industry, and enabling technologies. SET Ventures typically invests between €0.5 million to €6 million per portfolio company, aiming to take a seat on the supervisory board.

reMYND NV is a biotechnology company based in Leuven, Belgium, focused on developing disease-modifying treatments for neurodegenerative and metabolic disorders, including Alzheimer’s, Parkinson’s, and diabetes. The company is known for its investigational compounds, such as ReS19-T, aimed at treating Alzheimer’s, and ReS39, which targets diabetes. Additionally, reMYND is advancing ReS3-T, a program that addresses both Alzheimer’s and epilepsy by regulating neuronal activity. The company utilizes a phenotypic screening platform to discover small molecule treatments that counteract the toxicity of misfolded proteins associated with these diseases. As a contract research organization (CRO), reMYND also assists clients, including major pharmaceutical companies in the United States, Europe, and Japan, by providing in-vivo assessments of experimental treatments using proprietary mouse models. Founded in 2002, reMYND has established a reputation for delivering pivotal proof-of-concept data that supports drug development in protein misfolding disorders.

Gambit Financial Solutions is a Belgian company based in Liege, founded in 2007 by Georges Hübner and Séverine Plunus. It specializes in developing investment advice and risk management solutions, aiming to support the financial community with business solutions that simplify complex financial concepts into understandable and actionable information. The company offers portfolio optimization services and provides a digital investment platform that combines algorithmic power with expert investment knowledge.

Algonquin SA, founded in 1998 and based in Brussels, Belgium, specializes in the investment, ownership, operation, and franchising of hotels across Europe. The company manages a portfolio of 43 hotel assets, offering over 7,500 rooms with an estimated value of €1.8 billion. Approximately half of these hotels operate under Algonquin's own brands or well-known international franchises, while the remainder is managed through agreements with major international operators. Algonquin distinguishes itself by actively engaging in hotel operations, providing expertise in both daily management tasks and real estate matters. This dual role allows Algonquin to optimize operational efficiency and enhance the value of its properties, making it an attractive partner for institutional investors, family offices, and private equity firms seeking to collaborate in dedicated investment vehicles.

Ogeda SA is a clinical-stage drug discovery company based in Gosselies, Belgium, that specializes in the invention and development of small molecule drugs targeting G-Protein Coupled Receptors (GPCRs). Founded in 1994 and formerly known as Euroscreen, the company focuses on developing innovative therapies for women's health disorders, with its lead product, fezolinetant, currently in Phase II clinical development. In addition to fezolinetant, Ogeda is advancing other small molecules aimed at treating various endocrine, central nervous system, and inflammatory conditions. The company maintains facilities in Brussels and Paris, and operates as a subsidiary of Astellas Pharma Inc. Through its research, Ogeda seeks to provide effective treatment options for hormone-dependent pathologies and other related health issues.

Anteryon International, established in 2006, specializes in designing, manufacturing, and distributing high-precision optical components. Its product portfolio includes a wide range of lenses, laser modules, optical mirrors, filters, and custom opto-mechatronic assemblies. Serving diverse sectors such as medical, telecom, defense, and semiconductor industries, the company leverages its patented replication and opto-mechanical assembly technology, along with deep domain expertise, to deliver standard and customer-specific optical solutions. Headquartered in Eindhoven, the Netherlands, Anteryon International operates as a subsidiary of China Wafer Level CSP Co., Ltd.

Anteryon International, established in 2006, specializes in designing, manufacturing, and distributing high-precision optical components. Its product portfolio includes a wide range of lenses, laser modules, optical mirrors, filters, and custom opto-mechatronic assemblies. Serving diverse sectors such as medical, telecom, defense, and semiconductor industries, the company leverages its patented replication and opto-mechanical assembly technology, along with deep domain expertise, to deliver standard and customer-specific optical solutions. Headquartered in Eindhoven, the Netherlands, Anteryon International operates as a subsidiary of China Wafer Level CSP Co., Ltd.

Anteryon International, established in 2006, specializes in designing, manufacturing, and distributing high-precision optical components. Its product portfolio includes a wide range of lenses, laser modules, optical mirrors, filters, and custom opto-mechatronic assemblies. Serving diverse sectors such as medical, telecom, defense, and semiconductor industries, the company leverages its patented replication and opto-mechanical assembly technology, along with deep domain expertise, to deliver standard and customer-specific optical solutions. Headquartered in Eindhoven, the Netherlands, Anteryon International operates as a subsidiary of China Wafer Level CSP Co., Ltd.

LNG Holdings S.A. is a telecommunications company that specializes in providing managed bandwidth services, including broadband internet, telephony, and comprehensive IT solutions for commercial businesses and network operators. The company offers a range of services, from fiber-optic transmission circuits to high bit-rate IP services and co-location services at its Points of Presence (PoPs). LNG Holdings aims to establish itself as a leading provider of managed bandwidth services across Europe, with a strong presence in Germany, as well as extensive networks in France and Spain. It also maintains connections to major European cities, including Amsterdam, Brussels, and London. By delivering business-to-business network solutions, voice, video, and data communications, the company enables clients to access a variety of advanced services across a single internet network, often at significantly reduced costs.